Faculty Opinions recommendation of Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.

Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial

10.1016/s2213-8587(21)00139-x ◽

2021 ◽

Author(s):

Stephen E Gitelman ◽

Brian N Bundy ◽

Ele Ferrannini ◽

Noha Lim ◽

J Lori Blanchfield ◽

...

Keyword(s):

Type 1 Diabetes ◽

Imatinib Therapy ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Recent Onset ◽

Onset Type ◽

Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial

10.1016/s2213-8587(13)70111-6 ◽

2013 ◽

Vol 1 (4) ◽

pp. 284-294 ◽

Cited By ~ 103

Author(s):

Mark R Rigby ◽

Linda A DiMeglio ◽

Marc S Rendell ◽

Eric I Felner ◽

Jean M Dostou ◽

...

Keyword(s):

T Cells ◽

Type 1 Diabetes ◽

Memory T Cells ◽

Phase 2 ◽

Double Blind ◽

Double Blind Placebo ◽

Onset Type ◽

Phase 2 Trial ◽

New Onset

Imatinib Therapy for Patients with Recent-Onset Type 1 Diabetes: A Randomised Blinded Phase 2 Trial

SSRN Electronic Journal ◽

10.2139/ssrn.3773520 ◽

2021 ◽

Author(s):

Stephen E. Gitelman ◽

Brian N. Bundy ◽

Ele Ferrannini ◽

Noha Lim ◽

J. Lori Blanchfield ◽

...

Keyword(s):

Type 1 Diabetes ◽

Imatinib Therapy ◽

Phase 2 ◽

Recent Onset ◽

Onset Type ◽

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

The Lancet ◽

10.1016/s0140-6736(11)60886-6 ◽

2011 ◽

Vol 378 (9789) ◽

pp. 412-419 ◽

Cited By ~ 350

Author(s):

Tihamer Orban ◽

Brian Bundy ◽

Dorothy J Becker ◽

Linda A DiMeglio ◽

Stephen E Gitelman ◽

...

Keyword(s):

Type 1 Diabetes ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Recent Onset ◽

Onset Type

Anti-interleukin-21 antibody and liraglutide for the preservation of β-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial

10.1016/s2213-8587(21)00019-x ◽

2021 ◽

Vol 9 (4) ◽

pp. 212-224 ◽

Cited By ~ 3

Author(s):

Matthias von Herrath ◽

Stephen C Bain ◽

Bruce Bode ◽

Jesper Ole Clausen ◽

Ken Coppieters ◽

...

Keyword(s):

Cell Function ◽

Phase 2 ◽

Β Cell ◽

Double Blind ◽

Double Blind Placebo ◽

Recent Onset ◽

Phase 2 Trial ◽

Β Cell Function ◽

Interleukin 21

249-OR: A Randomized, Double-Blind Phase 2 Trial of the CXCR1/2 Inhibitor Ladarixin in Adult Patients with New-Onset Type 1 Diabetes

Diabetes ◽

10.2337/db20-249-or ◽

2020 ◽

Vol 69 (Supplement 1) ◽

pp. 249-OR

Author(s):

EMANUELE BOSI ◽

PAOLO POZZILLI ◽

FRANCESCO GIORGINO ◽

EFISIO COSSU ◽

THOMAS LINN ◽

...

Keyword(s):

Type 1 Diabetes ◽

Adult Patients ◽

Phase 2 ◽

Double Blind ◽

Onset Type ◽

Phase 2 Trial ◽

New Onset

Combination therapy with sitagliptin and lansoprazole in patients with recent-onset type 1 diabetes (REPAIR-T1D): 12-month results of a multicentre, randomised, placebo-controlled, phase 2 trial

10.1016/s2213-8587(14)70115-9 ◽

2014 ◽

Vol 2 (9) ◽

pp. 710-718 ◽

Cited By ~ 52

Author(s):

Kurt J Griffin ◽

Paul A Thompson ◽

Michael Gottschalk ◽

Jennifer H Kyllo ◽

Alex Rabinovitch

Keyword(s):

Type 1 Diabetes ◽

Combination Therapy ◽

Phase 2 ◽

Recent Onset ◽

Onset Type ◽

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial

10.1016/s2213-8587(13)70065-2 ◽

2013 ◽

Vol 1 (4) ◽

pp. 306-316 ◽

Cited By ~ 85

Author(s):

Stephen E Gitelman ◽

Peter A Gottlieb ◽

Mark R Rigby ◽

Eric I Felner ◽

Steven M Willi ◽

...

Keyword(s):

Type 1 Diabetes ◽

Antithymocyte Globulin ◽

Phase 2 ◽

Recent Onset ◽

Onset Type ◽

Faculty Opinions recommendation of Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955698.793460714 ◽

2012 ◽

Author(s):

Mark Peakman

Keyword(s):

Type 1 Diabetes ◽

Controlled Trial ◽

Double Blind ◽

Double Blind Placebo ◽

Recent Onset ◽

Onset Type

Faculty Opinions recommendation of Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717955696.793460711 ◽

2012 ◽

Author(s):

Mark Peakman

Keyword(s):

Type 1 Diabetes ◽

Glutamic Acid ◽

Glutamic Acid Decarboxylase ◽

Acid Decarboxylase ◽

Double Blind Trial ◽

Double Blind ◽

Recent Onset ◽

Blind Trial ◽

Onset Type